Skip to main content
. 2022 Mar 8;18:91. doi: 10.1186/s12917-022-03185-9

Table 2.

Distribution of antimicrobial and multidrug resistance among S. pseudintermedius isolated from canine specimens submitted to a veterinary diagnostic laboratory in Tennessee, USA (2006–2017)

2006–2008 2009–2011 2012–2014 2015–2017 Total
Aminoglycosides
 Gentamicin 19.3 (242/1256) 31.7 (482/1523) 29.2 (297/1016) 27.4 (241/881) 27.0 (1262/4676)***
β-lactams
 Ampicillin 84.7 (1020/1204) 83.9 (1277/1523) 84.5 (1566/1854) 84.2 (1499/1781) 84.3 (5362/6362)
 Cefoxitin 21.7 (272/1251) 19.9 (301/1510) 19.0 (353/1855) 22.4 (396/1768) 20.7 (1322/6384)
 Oxacillin 32.6 (411/1259) 36.9 (559/1514) 34.3 (638/1861) 34.8 (622/1790) 34.7 (2230/6424)
Fluoroquinolones
 Marbofloxacin 31 (385/1244) 30.1 (453/1504) 28.3 (523/1848) 29.1 (412/1417) 29.5 (1773/6013)
Folate inhibitors
 TMSa 42.1 (529/1258) 42.7 (649/1521) 42.5 (791/1863) 49.5 (894/1805) 44.4 (2863/6447)***
Lincosamides
 Clindamycin 38.9 (489/1256) 40.3 (613/1522) 39.1 (727/1859) 38.2 (688/1801) 39.1 (2517/6438)
Macrolides
 Erythromycin 38.4 (483/1257) 39.7 (604/1522) 39.1 (726/1858) 38.0 (685/1802) 38.8 (2498/6439)
Phenicols
 Chloramphenicol 2.5 (31/1258) 3.3 (50/1523) 5.8 (107/1862) 8.7 (157/1805) 5.4 (345/6448)***
Tetracyclines
 Tetracycline 52.4 (659/1257) 50.1 (762/1521) 45.9 (855/1862) 44.8 (797/1780) 47.9 (3073/6420)***
AMRb 87.1 (1096/1259) 86.8 (1322/1523) 86.5 (1611/1863) 86.7 (1567/1808) 86.7 (5596/6453)
MDRc 44.2 (557/1259) 45.8 (697/1523) 45.1 (840/1863) 46.4 (839/1808) 45.5 (2933/6453)
MRSPd 26.1 (300/1148) 32.5 (479/1473) 31.7 (585/1844) 31.5 (544/1730) 30.8 (1908/6195)*

aTrimethoprim/sulfamethoxazole

bAntimicrobial resistance

cMultidrug resistance

dMethicillin-resistant S. pseudintermedius, based on oxacillin disk diffusion testing confirmed with positive mecA PCR

*p <  0.05, **p <  0.01, ***p < 0.0001 for Cochran-Armitage trend test